A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
Clinical trial NCT07335588 · RECRUITING
Trial details
- NCT number
- NCT07335588
- Sponsor
- LEO Pharma
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-03-10
- Enrollment
- 652
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.